| Ganglioside GD3 as a RAFT Component in Cell Death Regulation. | |
| | |
MedLine Citation:
|
PMID: 21554197 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Subcellular organelles such as mitochondria, endoplasmic reticulum and the Golgi complex are involved in the progression of cell death program. Recent evidence unveils that Fas ligand-mediated apoptosis induces scrambling of mitochondrial and secretory organelles via a global alteration of membrane traffic that is modulated by apical caspases. On the basis of the biochemical nature of lipid rafts, composed by sphingolipids, including gangliosides and sphingomyelin, cholesterol and signaling proteins, it has been suggested that they are part of this traffic and can participate in cell remodelling leading to cell death program execution. Although detected in various cell types, the role of lipid rafts in apoptosis has been mostly studied in T cells, where the physiological apoptotic program occurs through CD95/Fas. In this review, the possible contribution of lipid rafts to the cascade of events leading to T cell apoptosis after CD95/Fas ligation is summarized. We focused on the paradigmatic component of rafts GD3, which can proceed from the cell plasma membrane (and/or from trans Golgi network) to the mitochondria via a microtubule-dependent mechanism. This transport may be regulated by CLIPR-59, a new CLIP-170-related protein, involved in the regulation of microtubule dynamics. Particular attention has been given to mitochondrial raft-like microdomains, which may represent preferential sites where key reactions take place. Indeed, GD3, by interacting with mitochondrial raft-like microdomains, may trigger specific events involved in the apoptogenic program, including mitochondria hyperpolarization and depolarization, fission-associated changes, megapore formation and release of apoptogenic factors. These findings introduce an additional task for identifying new molecular target(s) of anti-cancer agents. |
| | |
Authors:
|
Maurizio Sorice; Tina Garofalo; Roberta Misasi; Valeria Manganelli; Rosa Vona; Walter Malorni |
Related Documents
:
|
12718877 - Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by e... 21545297 - Lentivirus-mediated rna interference targeting bax inhibitor-1 suppresses ex vivo cell ... 21151477 - Nitric oxide-mediated tumoricidal activity of murine microglial cells. 21112127 - Ccaat/enhancer binding protein delta (cebpd) elevating ptx3 expression inhibits macroph... 12393587 - The death-promoting activity of p53 can be inhibited by distinct signaling pathways. 7515917 - Recombinant soluble cd14 inhibits lps-induced tumor necrosis factor-alpha production by... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-5-9 |
Journal Detail:
|
Title: Anti-cancer agents in medicinal chemistry Volume: - ISSN: 1875-5992 ISO Abbreviation: - Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-5-10 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101265649 Medline TA: Anticancer Agents Med Chem Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Experimental Medicine, "Sapienza" University of Rome, Italy. maurizio.sorice@uniroma1.it. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The effect of mesenchymal stromal cell - hyaluronic acid hydrogel constructs on immunophenotype of m...
Next Document: Alteration of Ceramide 1-O-Functionalization as a Promising Approach for Cancer Therapy.